The Trump administration has highlighted synthetic hemp products containing high levels of THC as a priority enforcement area in its recently released National Drug Control Strategy.

The administration characterized these products as a "growing concern" that have proliferated in recent years. The synthetic hemp products in question contain elevated levels of tetrahydrocannabinol (THC), the psychoactive compound found in marijuana.

The focus on these products represents part of the administration's broader drug control efforts. The timing comes as various hemp-derived products have become more widely available in retail markets across the United States.

The National Drug Control Strategy document signals the administration's intent to increase scrutiny of these synthetic hemp products, though specific enforcement actions or regulatory changes were not immediately detailed in the initial announcement.